We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

142 hedge funds and large institutions have $1.14B invested in Immunogen Inc in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

71% more call options, than puts

Call options by funds: $8.3M | Put options by funds: $4.85M

23% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 39

5% more funds holding

Funds holding: 135142 (+7)

3% more capital invested

Capital invested by funds: $1.11B → $1.14B (+$32.6M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
142
Holders Change
+7
Holders Change %
+5.19%
% of All Funds
4.1%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
48
Reduced
39
Closed
11
Calls
$8.3M
Puts
$4.85M
Net Calls
+$3.45M
Net Calls Change
+$3.18M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS AM
76
UBS AM
Illinois
$464K +$30K +1,900 +7%
PI
77
Placemark Investments
Illinois
$418K +$99.2K +6,295 +29%
Royal Bank of Canada
78
Royal Bank of Canada
Ontario, Canada
$409K +$76.5K +4,855 +22%
SCM
79
Stonebridge Capital Management
California
$389K +$62.1K +3,940 +18%
EMG
80
Ellington Management Group
Connecticut
$388K +$410K +26,000 New
AQR Capital Management
81
AQR Capital Management
Connecticut
$345K
Neuberger Berman Group
82
Neuberger Berman Group
New York
$343K +$27.7K +1,755 +8%
PG
83
PEAK6 Group
Illinois
$339K +$358K +22,683 New
William Blair & Company
84
William Blair & Company
Illinois
$330K -$31.5K -2,000 -8%
TAM
85
Tocqueville Asset Management
New York
$320K -$126K -8,000 -27%
T. Rowe Price Associates
86
T. Rowe Price Associates
Maryland
$318K
Comerica Bank
87
Comerica Bank
Texas
$311K +$3.34K +212 +1%
FBA
88
Front Barnett Associates
Illinois
$309K
Principal Financial Group
89
Principal Financial Group
Iowa
$305K -$136K -8,614 -30%
SC
90
Scotia Capital
Ontario, Canada
$293K +$309K +19,600 New
AT
91
Arden Trust
Delaware
$276K -$13.8K -873 -5%
Cambridge Investment Research Advisors
92
Cambridge Investment Research Advisors
Iowa
$274K +$46.5K +2,950 +19%
AG
93
Algert Global
California
$274K +$289K +18,320 New
WMSA
94
Weiss Multi-Strategy Advisers
New York
$217K +$41.5K +2,630 +22%
V
95
Veritable
Delaware
$199K -$6.38K -405 -3%
Creative Planning
96
Creative Planning
Kansas
$195K -$43.7K -2,771 -18%
N
97
Nuveen
North Carolina
$195K
Group One Trading
98
Group One Trading
Illinois
$187K -$525K -33,282 -73%
Commonwealth Equity Services
99
Commonwealth Equity Services
Massachusetts
$180K -$24.1K -1,531 -11%
DC
100
Deere & Company
Illinois
$180K

IMGN Hedge Fund Activity: Q1 2014 in Review

142 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2014, worth a combined $1.14B — up 2.9% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new IMGN positions and 11 closed out — a net gain of 8 holders — while 48 added to existing stakes and 39 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $16M. The largest seller was Norges Bank, cutting an estimated $12.1M.

  • 142 institutional investors held Immunogen Inc (IMGN) as of Q1 2014, up from 135 in Q4 2013.
  • Funds reported $1.14B of Immunogen Inc stock for Q1 2014, up 2.9% quarter-over-quarter.
  • 19 funds opened new Immunogen Inc positions in Q1 2014 and 11 closed out, a net change of +8 holders.
  • The largest Immunogen Inc buyer in Q1 2014 was First Trust Advisors, an estimated $16M added.
  • The largest Immunogen Inc seller in Q1 2014 was Norges Bank, an estimated $12.1M sold.

Based on aggregated 13F filings for Q1 2014.